Projects per year
Personal profile
Area of Expertise
The first aim is to screen compounds that will attenuate the subjective and reinforcing effects of abused drugs as part of a NIDA-funded contract searching for effective treatment drugs for addiction to cocaine, methamphetamine, nicotine, and marijuana.
The second aim is to evaluate the potential abuse liability of novel designer drugs that are increasingly available as "legal" alternatives to controlled substances. We use drug discrimination procedures which assess the subjective effects of common drugs of abuse such as cocaine, methamphetamine, nicotine, and marijuana, with designer drugs like MDMA (Ecstasy), with opioids like morphine, or with hallucinogens like LSD. We also test the reinforcing/rewarding effects of drugs using the conditioned place preference and self-administration assays.
Education/Academic qualification
BA in Behavioral Science, The University of Chicago
MA in Behavior Science, University of Houston
PhD in Psychology , Utah State University
Fingerprint
- 1 Similar Profiles
Network
Projects
- 7 Finished
-
Using rodent behavioral models to identify substance abuse pharmacotherapies
Forster, M., Gatch, M., Sumien, N. & Shetty, R.
NIDA: National Institute on Drug Abuse
20/09/18 → 3/01/23
Project: Research
-
Evaluation of Synthetic Opioid Substances using the Drug Discrimination Assay
1/09/18 → 31/08/19
Project: Research
-
-
Evaluation of Synthetic Opioid Substances using the Drug Discrimination Assay
1/08/17 → 31/07/18
Project: Research
-
Rodent Testing to Identify Pharmacotherapies for Substance Dependence
NIDA: National Institute on Drug Abuse
4/01/16 → 20/09/18
Project: Research
-
Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants
Shetty, R. A., Hoch, A. C., Sumien, N., Forster, M. J. & Gatch, M. B., May 2023, In: Journal of Psychopharmacology. 37, 5, p. 520-528 9 p.Research output: Contribution to journal › Article › peer-review
-
Behavioral pharmacology of five novel synthetic cannabinoids
Gatch, M. B., Tourigny, A., Shetty, R. A. & Forster, M. J., 1 Apr 2022, In: Behavioural pharmacology. 33, 23, p. 175-183 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Behavioral effects of four novel synthetic cathinone analogs in rodents
Gatch, M. B., Shetty, R. A., Sumien, N. & Forster, M. J., Jul 2021, In: Addiction Biology. 26, 4, e12987.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Discriminative Stimulus Effects of Substituted Tryptamines in Rats
Gatch, M. B., Hoch, A. & Carbonaro, T. M., 9 Apr 2021, In: ACS Pharmacology and Translational Science. 4, 2, p. 467-471 5 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate
Carbonaro, T. M., Nguyen, V., Forster, M. J., Gatch, M. B. & Prokai, L., 1 Sep 2020, In: Neuropharmacology. 174, 108152.Research output: Contribution to journal › Article › peer-review